金吾财讯 | 映恩生物(09606)首挂开报181港元，较招股价高91.33%，盘前成交473.63万股，成交额7.82亿港元，不计手续费，每手100股，账面赚8640港元。据招股结果显示，股份每股定价94.6港元，集资16.4亿港元，净额约15.13亿港元，一手中签率80.01%，认购10手可稳获一手。股份于公开发售部分接获26857份有效申请，认购额115.14倍；国际发售部分认购额13.52倍。
金吾财讯 | 映恩生物(09606)首挂开报181港元，较招股价高91.33%，盘前成交473.63万股，成交额7.82亿港元，不计手续费，每手100股，账面赚8640港元。据招股结果显示，股份每股定价94.6港元，集资16.4亿港元，净额约15.13亿港元，一手中签率80.01%，认购10手可稳获一手。股份于公开发售部分接获26857份有效申请，认购额115.14倍；国际发售部分认购额13.52倍。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.